Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Advanced Pancreatic Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Ruijin-Hainan Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Qionghai, Hainan, China

Study leads

Baiyong Shen, M.D.&Ph.D
Study Director
Ruijin Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Dose Escalation of ES502 in Patients With Advanced Pancreatic Cancer

Pancreatic Cancer

Abroad (travel likely)RecruitingEARLY_PHASE1

Shanghai, China

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Cancer · Advanced Cancer · Locally Advanced Carcinoma

Abroad (travel likely)RecruitingPHASE1

Los Angeles, United States · Sarasota, United States

Clinical Study of 177Lu-CTR-FAPI In the Treatment of Patients With Advanced, Metastatic Solid Tumors

Pancreatic Cancer

Abroad (travel likely)RecruitingEARLY_PHASE1

Shanghai, China

An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With Pancreatic Cancer

Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE2

Nanjing, China · Tianjin, China